Literature DB >> 35074483

Structural Investigations of Full-Length Insulin Receptor Dynamics and Signalling.

Jeppe Nielsen1, Jakob Brandt2, Thomas Boesen3, Tina Hummelshøj2, Rita Slaaby2, Gerd Schluckebier4, Poul Nissen5.   

Abstract

Insulin regulates glucose homeostasis via binding and activation of the insulin receptor dimer at two distinct pairs of binding sites 1 and 2. Here, we present cryo-EM studies of full-length human insulin receptor (hIR) in an active state obtained at non-saturating, physiologically relevant insulin conditions. Insulin binds asymmetrically to the receptor under these conditions, occupying up to three of the four possible binding sites. Deletion analysis of the receptor together with site specific peptides and insulin analogs used in binding studies show that both sites 1 and 2 are required for high insulin affinity. We identify a homotypic interaction of the fibronectin type III domain (FnIII-3) of IR resulting in tight interaction of membrane proximal domains of the active, asymmetric receptor dimer. Our results show how insulin binding at two distinct types of sites disrupts the autoinhibited apo-IR dimer and stabilizes the active dimer. We propose an insulin binding and activation mechanism, which is sequential, exhibits negative cooperativity, and is based on asymmetry at physiological insulin concentrations with one to three insulin molecules activating IR.
Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  insulin; insulin receptor; insulin receptor dimer; insulin receptor dynamics; insulin receptor sites

Mesh:

Substances:

Year:  2022        PMID: 35074483     DOI: 10.1016/j.jmb.2022.167458

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  4 in total

Review 1.  Unconventional insulins from predators and pathogens.

Authors:  Sophie Heiden Laugesen; Danny Hung-Chieh Chou; Helena Safavi-Hemami
Journal:  Nat Chem Biol       Date:  2022-06-27       Impact factor: 16.174

2.  How insulin-like growth factor I binds to a hybrid insulin receptor type 1 insulin-like growth factor receptor.

Authors:  Yibin Xu; Mai B Margetts; Hari Venugopal; John G Menting; Nicholas S Kirk; Tristan I Croll; Carlie Delaine; Briony E Forbes; Michael C Lawrence
Journal:  Structure       Date:  2022-06-03       Impact factor: 5.871

3.  Minimizing Mitogenic Potency of Insulin Analogues Through Modification of a Disulfide Bond.

Authors:  Shee Chee Ong; Alessia Belgi; Allanah L Merriman; Carlie A Delaine; Bianca van Lierop; Sofianos Andrikopoulos; Andrea J Robinson; Briony E Forbes
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-27       Impact factor: 6.055

4.  Activation of the human insulin receptor by non-insulin-related peptides.

Authors:  Nicholas S Kirk; Qi Chen; Yingzhe Ginger Wu; Anastasia L Asante; Haitao Hu; Juan F Espinosa; Francisco Martínez-Olid; Mai B Margetts; Faiz A Mohammed; Vladislav V Kiselyov; David G Barrett; Michael C Lawrence
Journal:  Nat Commun       Date:  2022-09-28       Impact factor: 17.694

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.